BiomX Inc (AMEX:PHGE)’s traded shares stood at 0.12 million during the last session, with the company’s beta value hitting 1.43.The PHGE share’s 52-week high remains $3.86, putting it -777.27% down since that peak but still an impressive 22.73% since price per share fell to its 52-week low of $0.34. The company has a valuation of $11.52M, with an average of 0.15 million shares in intraday trading volume over the past 10 days and average of 149.56K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for BiomX Inc (PHGE), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give PHGE a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.19.
BiomX Inc (AMEX:PHGE) trade information
The 5-day price performance for the stock is -2.22%, and -12.18% over 30 days. With these gigs, the year-to-date price performance is -87.10%. Short interest in BiomX Inc (AMEX:PHGE) saw shorts transact 0.24 million shares and set a 1.93 days time to cover.
The extremes give us $2 and $2 for target low and target high price respectively. As such, PHGE has been trading -354.55% off suggested target high and -354.55% from its likely low.
BiomX Inc (PHGE) estimates and forecasts
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 47.40% for the past 5-year period. While 2025 is set for a 61.16% return in earnings, projections for the next 5 years are at 22.65% annually.
PHGE Dividends
BiomX Inc has its next earnings report out on 2025-May-15. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
BiomX Inc (AMEX:PHGE)’s Major holders
BiomX Inc insiders hold 19.08% of total outstanding shares, with institutional holders owning 47.70% of the shares at 58.95% float percentage. In total, 47.70% institutions holds shares in the company, led by ORBIMED ADVISORS LLC. As of 2024-06-30, the company held over 13.77 million shares (or 22.1113% of shares), all amounting to roughly $4.63 million.
The next major institution holding the largest number of shares is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) with 6.11 million shares, or about 9.8088% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $2.05 million.
